Thursday, July 2, 2026 See who Washington just made rich Go Pro · $40/mo →
Money Racket
Who Cashes In When Washington Moves
DEFENSEThe F-35 Sustainment Lock-In: Why the Pentagon's Most Expensive Program Keeps Paying One Company ForevertodayHEALTHCARE340B Under Fire: The Hospital Drug Discount Fight That Hits CVS and HCA Where It Hurts4 weeks agoTRADE & TARIFFSThe Tariff Refund Portal Is Open and Companies Are Cashing In — Nike and FedEx Are the Names to WatchyesterdayHEALTHCAREGLP-1 Coverage Mandate: The Federal Obesity Drug Windfall for Lilly and Novo4 weeks agoMARKETSSupreme Court Gives Trump FTC Firing Power — Antitrust Enforcement Just Got More PoliticalyesterdayHEALTHCAREFDA Accelerated Approval Reform: The Vertex Model Every Biotech Wants4 weeks agoTRADE & TARIFFSTrump's Fertilizer Tariff Suspension Cuts Input Costs for Farmers — and Squeezes Domestic ProducersyesterdayHEALTHCAREThe Medicare Drug Negotiation Trade: Who Gets Hurt When Washington Sets the Price4 weeks agoDEFENSEThe Nuclear Triad Upgrade Cycle: Three Legs, Three Winners, Decades of Locked-In SpendingyesterdayCRYPTOThe Anti-CBDC Play: No Digital Dollar Means Private Rails Win4 weeks agoDEFENSEWhen the Pentagon Classifies a Budget Line: The Black Budget Trade2 days agoCRYPTOThe Toll Booth at the Top of the Bitcoin ETF Stack4 weeks agoDEFENSENATO's 2% Mandate Is a Revenue Stream Disguised as an Alliance Obligation3 days agoCRYPTOThe IRS Closes the Crypto Wash-Sale Loophole — and Robinhood Collects the Toll4 weeks agoDEFENSEThe Drone Proliferation Trade: Washington's Shift to Attritable Unmanned Systems Creates a Recurring Revenue Stream3 days agoCRYPTOThe Debanking Era Is Over. HOOD and Block Are Next in Line at the Window.4 weeks agoDEFENSEThe Hypersonic Arms Race Has a Bottleneck — and Three Contractors Own It4 days agoCRYPTOMining the Grid: How EPA and Energy Policy Set the Spread for Proof-of-Work Miners3 weeks agoDEFENSEThe Pentagon's AI Mandate: Why Defense Data Platforms Are Now a Weapons Program5 days agoCRYPTOThe Stablecoin Bill: Who Controls the On-Ramp When Congress Licenses It3 weeks agoDEFENSEIron Dome and the FMS Pipeline: How Middle East Tensions Fund Missile Defense Primes5 days agoCRYPTOBitcoin as Reserve Asset: The Federal Legitimacy Trade3 weeks agoENERGYThe SPR Refill Trade: Who Gets Paid When Washington Buys Oil6 days agoCRYPTOThe SEC Retreat: How a Friendlier Regulator Unlocks Coinbase's Business Model3 weeks agoENERGYLNG Export Licenses: How a FERC Approval Mints a Monopolylast weekTECHThe Federal Data Center Mandate: How Washington's AI Spending Flows to Hardware3 weeks agoENERGYThe BLM Calendar That Moves COP and OXYlast weekTECHThe Domestic Equipment Play: How Foreign Chip Tool Restrictions Hand Applied Materials a Structural Edge3 weeks agoENERGYThe Permian Methane Rule: Why Stricter EPA Standards Are a HAL and SLB Giftlast weekTECHThe AI Diffusion Rule Is Picking Winners Inside the Chip Stack — and It Is Not Who You Think3 weeks agoENERGYThe Permit Logjam Is Breaking: Williams and Kinder Morgan Hold the Keyslast weekTECHThe HBM Monopoly: How Federal Memory Standards Lock In Micron3 weeks agoENERGYThe Tax Code Oil Patch: Who Gets Crushed If Washington Kills the IDC Deductionlast weekTECHThe Tariff Arbitrage: How Chip Import Duties Reshape the Foundry Map3 weeks agoENERGYThe Pipe Tax: How Section 232 Steel Tariffs Rewire U.S. Drilling Economicslast weekTECHThe Chip Stack Below the Pentagon's AI Buildup3 weeks agoENERGYSanctions Relief and the LNG Arbitrage: When State Department Decisions Move the Henry Hublast weekTECHThe CHIPS Act Subsidy Ladder: Who Actually Receives the $39 Billion3 weeks agoENERGYThe Nuclear Production Tax Credit Trade: Who Gets Paid to Keep Old Reactors Alivelast weekENERGYThe Grid Hardening Bill Trade: How Federal Transmission Investment Lifts the Equipment Makers2 weeks agoENERGYThe Uranium Supply Squeeze: How the Russian Import Ban Flows to Cameco and Centruslast weekTECHThe Export Control Squeeze: BIS Chip Rules Are Splitting the AI Hardware Market in Two2 weeks agoENERGYThe SMR Funding Funnel: How DOE's Loan Billions Flow to Small Modular Reactorslast weekENERGYThe Only U.S. HALEU Cascade: How Centrus Became the Gatekeeper to the Advanced Reactor Boom2 weeks agoENERGYWashington Plugs AI Into Reactors: The Behind-the-Meter Nuclear Offtake Trade2 weeks agoENERGYThe Grid Reliability Mandate: FERC's Capacity Market Rules Are Writing Checks to Nuclear2 weeks agoENERGYThe Nuclear Restart Order: Only One Operator Has Actually Flipped the Switch2 weeks ago
Healthcare

Healthcare

The latest in healthcare for medical-aesthetics practice owners.

The Medicare Drug Negotiation Trade: Who Gets Hurt When Washington Sets the Price Healthcare

The Medicare Drug Negotiation Trade: Who Gets Hurt When Washington Sets the Price

The IRA's Maximum Fair Price machine went live January 1, 2026 — squeezing blockbuster small-molecule revenue at Pfizer and Novo Nordisk while Vertex's rare-disease fortress stands largely intact.

Jun 4, 2026
 FDA Accelerated Approval Reform: The Vertex Model Every Biotech Wants Healthcare

FDA Accelerated Approval Reform: The Vertex Model Every Biotech Wants

Congressional pressure to harden post-market confirmation requirements is quietly repricing biotech risk — rewarding companies with durable clinical proof and punishing pipeline plays that live on surrogate endpoints.

Jun 3, 2026
 GLP-1 Coverage Mandate: The Federal Obesity Drug Windfall for Lilly and Novo Healthcare

GLP-1 Coverage Mandate: The Federal Obesity Drug Windfall for Lilly and Novo

A CMS rule forcing Medicare and Medicaid to cover obesity drugs isn't a health story — it's a guaranteed revenue pipeline to two pharma giants, with insurers stuck footing the bill.

Jun 3, 2026
 340B Under Fire: The Hospital Drug Discount Fight That Hits CVS and HCA Where It Hurts Healthcare

340B Under Fire: The Hospital Drug Discount Fight That Hits CVS and HCA Where It Hurts

Federal efforts to restructure the 340B drug discount program are turning a quiet Washington policy fight into a live P&L event for CVS Health's specialty pharmacy unit and HCA's safety-net revenue base.

Jun 2, 2026
 HHS Hospital Merger Scrutiny: Why HCA Runs the Table When Smaller Systems Can't Healthcare

HHS Hospital Merger Scrutiny: Why HCA Runs the Table When Smaller Systems Can't

Heightened antitrust review of hospital consolidation is blocking regional rivals from scaling — and quietly cementing HCA Healthcare's grip on the most profitable Sun Belt markets.

Jun 1, 2026
 The Biosimilar Promotion Trade: When FDA Pushes Interchangeability, Pfizer Collects Healthcare

The Biosimilar Promotion Trade: When FDA Pushes Interchangeability, Pfizer Collects

FDA's accelerating push to grant biosimilars interchangeability status quietly dismantles branded biologic moats — and hands Pfizer a structural volume windfall at Lilly and Novo Nordisk's expense.

Jun 1, 2026
 Medicaid Work Requirements Return: The Managed Care Revenue Equation Healthcare

Medicaid Work Requirements Return: The Managed Care Revenue Equation

Federal waivers reinstating Medicaid work requirements will shrink enrollment rolls — and the per-member-per-month revenue that UNH and CVS count on.

May 31, 2026
 The Pandemic Annuity: How BARDA Turns Preparedness Into Recurring Revenue for Moderna Healthcare

The Pandemic Annuity: How BARDA Turns Preparedness Into Recurring Revenue for Moderna

Federal pandemic-preparedness procurement cycles quietly funnel hundreds of millions in contract revenue to mRNA platform holders every budget year — and consensus models mostly miss it.

May 30, 2026
Free alerts

Free: catalyst alerts, straight to your inbox.

Get the White House orders, federal contracts, and FDA decisions that move money — with who cashes in — free. Unsubscribe in one click.

Free · weekly · unsubscribe anytime. Privacy.

Money Racket Pro

By the time it's news, the money's already moved.

The contract award, the executive order, the tariff cut — it mints winners before the financial press connects the dots. Pro gets you there first: what happened, who cashes in, and exactly what to watch — in a two-minute read.

Go Pro · $40/mo The policy-to-profit brief. Cancel anytime.
The pre-market brief · Mon–Sat, 7:45am ET Go Pro · $40/mo →